Background: Human prostate basal cells expressing alpha-6 integrin (CD49f Hi ) and/or CD44 form prostaspheres in vitro. This functional trait is often correlated with stem/progenitor (S/P) activity, including the ability to self-renew and induce differentiated tubules in vivo. Antigenic profiles that distinguish tubule-initiating prostate stem cells (SCs) from progenitor cells (PCs) and mature luminal cells (LCs) with less regenerative potential are unknown.
Conclusions/Significance: Our data delineates antigenic profiles that functionally distinguish human prostate epithelial subpopulations, including putative SCs that display superior tubule initiation capability and induce differentiated ductal/ acini structures, sphere-forming PCs with relatively decreased tubule initiation activity, and terminally differentiated LCs that lack both sphere-forming and tubule-initiation activity. The results clearly demonstrate that sphere-forming ability is not predictive of tubule-initiation activity. The subpopulations identified are of interest because they may play distinct roles as cells of origin in the development of prostatic diseases, including cancer.
Introduction
Human adult prostate S/Ps are characterized by surface marker expression, as well as functional traits, including the ability to selfrenewal and differentiate into multiple lineages [1, 2, 3, 4, 5] . Markers that have been utilized to isolate human prostate S/Ps include Trop2, CD44, alpha 2 beta 1 -integrin Hi , alpha 6 -integrin Hi (CD49f), and CD133 [1, 2, 4, 6] . However, a consensus does not exist regarding the antigenic profile of a functionally pure human prostate SC population and how to distinguish multipotent tubule-initiating SCs from progenitors with more limited potential. Making such a distinction may have important implications in understanding the etiology of prostatic disease, including benign prostatic hypertrophy and cancer.
Sphere-forming cells isolated from dissociated primary tissues are enriched in S/P cells in multiple organ systems [7, 8, 9, 10] . In the human prostate, sphere-forming capability enables the selection of a subpopulation of epithelial cells with SC-like traits, including self-renewal and the ability to differentiate into tubular structures when implanted into immunocompromised mice [1, 4] . Previous studies evaluating the antigenic profile of cells capable of forming prostaspheres indicate that they reside within the basal layer of normal prostatic ducts [1, 4, 11, 12] . onsequently, the combination of Trop2 and CD49f
Hi expression enables isolation of the basal cell fraction (Trop2 + CD49f Hi ), which exclusively forms spheres, regenerates benign tubules, and demonstrates malignant transformation after genetic manipulations [1, 4, 6] . Sphere-forming cells are rare in prostate subpopulations that display luminal profiles (Trop2
+

CD49f
Lo or Trop2 + CD44 2 ) [1, 4] . Subdivision of the basal population and enrichment of a sphereforming and/or tubule-regenerating SC population has yet to be accomplished. However, a functional delineation of the human prostate cellular hierarchy, in addition to basal/luminal profile, could provide more specific insight about the cells of origin for prostate cancer and the pathways utilized by normal SCs that may become corrupted in prostate disease. The aim of this work is to employ in vitro sphere culture and in vivo tissue regeneration assays to interrogate combinations of surface antigens that may further subdivide human prostate epithelial cells and enable functional separation of tubule-initiating SCs from progenitors with more limited capabilities. In this report, we accomplish these goals by incorporating a refined tissue regeneration assay, in which human fetal prostate stroma (hFPS) is utilized to induce tubule formation/differentiation in a fully humanized system. Our results demonstrate that the combination of Epithelial Cell Adhesion Molecule (Epcam), CD44, and CD49f can be used to isolate three distinct populations: (i) a putative prostate SC population that does not form spheres, but induces relatively robust tubule regeneration, (ii) PCs possessing maximal sphere-forming ability, but decreased tubule-initiation capability, and (iii) terminally differentiated LCs that lack both sphere-forming and tissue regenerating potential. The uncoupling of sphere-forming and tubule-initiating functions indicates that human prostate cells with the most potential for niche interaction and tubule development appear to be quiescent in sphere-forming culture conditions.
Results
Epcam and CD44 enable separation of prostate cell lineages.
Epcam/Trop1 is a pan-epithelial antigen that is also expressed on most carcinomas, including prostate cancer [13] . In benign human prostate, immunohistochemical (IHC) staining demonstrates confinement of Epcam expression to epithelial cells that compose prostate ducts and acini ( Figure 1A ). CD44 is a single pass transmembrane glycoprotein involved in cell-cell matrix adhesion, cell signaling, inflammation, and cell migration ( [14] ). In the benign human prostate, CD44 marks basal cells and rare neuroendocrine cells [15] . Based on the expression pattern of Epcam and CD44 observed in IHC analysis of benign prostate tubules, it appears that Epcam +
CD44
+ cells compose the basal layer, while Epcam +
2 cells appear predominantly luminal ( Figure 1A ). We hypothesized that fractionating total prostate cells based upon the combination of Epcam and CD44 expression profiles could be a first step in determining antigenic profiles that delineate human prostate cellular hierarchy, by enabling basal and luminal separation. An advantage of both Epcam and CD44 is that conjugated magnetic beads are readily available that enable rapid fractionation of prostate cells without the need for a cell sorter. This may increase the accessibility and feasibility of fractionating surgical specimens. FACS analysis of total prostate epithelial cells using fluorescent antibodies to detect Epcam and CD44 expression demonstrate clear separation of (Epcam + ) epithelial cells from (Epcam 2 ) stromal/blood cells ( Figure 1B ). Although FACS analysis demonstrates that separation based on CD44 expression is not as distinct as Epcam, both CD44 + and CD44 2 fractions were obtained via cell sorting or magnetic beads separation ( Figure 1B) .
Expression of basal-and luminal-specific genes correlates with Epcam/CD44 status.
Prostate basal and luminal cells can be distinguished based on marker profile, in addition to architectural organization. The tumor protein p63 is a hallmark indicator of basal cells, which also express relatively low levels of AR and PSA [16, 17] . On the other hand, luminal cells lack p63, but express strong levels of AR, PSA, and cytokeratin 8 (CK8) [18, 19] . In order to confirm enrichment of basal and luminal cells after fractionation based on Epcam/ CD44 expression, quantitative RT-PCR analysis was performed on total RNA isolated from fractionated cells with primers targeting basal-specific and luminal-specific genes ( Figure 1C) [19, 20] .
We have previously shown that prostate S/P cells are capable of prostasphere formation in vitro [4] . Additionally, we have found that basal cells are exclusively capable of forming spheres [1] . Therefore sphere-forming capability of Epcam 
HFPS Supports Prostate Tissue Regeneration Induced by
Adult Human Prostate Cells In Vivo.
We have previously described regeneration of human prostate tissue following implantation of adult prostate cells (or prostaspheres) combined with rat urogenital sinus mesenchyme (rUGSM) and MatrigelH into Non-Obese Diabetic Severely Combined Immunodeficient mice that are Interluekin-2 Receptor Null (SCID-NOD IL2grNULL ) [4, 6] . In an effort to employ a fully humanized prostate tissue regeneration system, rUGSM was replaced with human prostate stromal cells cultured from dissociated fetal prostate tissue ( Figure 2 ). Histological evaluation of fetal prostate specimens demonstrates abundant stroma surrounding the prostatic urethra with developing epithelial buds/tubules (Figure 2A ). FBS-supplemented culture media supported the outgrowth of a nearly pure (Epcam-negative) human fetal stromal cell population (hFPS) that could be passaged continuously for more than 10 generations ( Figure 2B and data not shown). Cryopreservation of hFPS, followed by thaw and re-culture enabled further expansion of these cells prior to use in vivo. When hFPS was combined with freshly isolated adult prostate epithelial cells ( Figure 2C ) or sphere-forming cells (data not shown) and MatrigelH, followed by subcutaneous implantation into SCID-NOD IL2grNULL mice, epithelial cord-like structures formed as early as 6 weeks (data not shown). Fully differentiated ductal/acinar structures with PSA-expressing luminal cells were prominent by 6 months ( Figure 2C ). Epithelial cords and/or tubular structures failed to form if MatrigelH and hFPS were recombined in the absence of prostate epithelial cells ( Figure S1 ). No differences in tubule development were noted in grafts induced by rUGSM or hFPS ( Figure S1 ). All structures typically identified in benign prostate surgical specimens were present in hFPS regenerated grafts, including epithelial cords, corporal amylacea, and secretion-filled ducts/acini. Layers of epithelial cells expressing basal markers (K5, P63), luminal markers (K8, AR, PSA), or a combination of both were also identified ( Figure 2C ). HFPS was generated from 6 different fetal specimens and all demonstrated similar growth in culture, FACS profile, and ability to support tubular outgrowth when combined with adult prostate epithelial cells (data not shown).
Tubule initiating capability is prevalent in the nonsphere-forming Epcam +
CD44
2 luminal-enriched cell fraction.
Although sphere formation is a common feature of S/Ps, one critical characteristic that prostate SCs must demonstrate is the ability to induce new tubule formation inclusive of ducts/acini composed of both basal and luminal cells. Prostate tissue regeneration assays have been utilized to interrogate the tubule initiation capability of putative S/P populations in mouse and human [4, 21, 22] . In these assays, total or fractionated cells obtained from fetal or adult prostate tissues are combined with supportive stroma (i.e., UGSM) followed by sub-renal implantation as a collagen graft or subcutaneous implantation with MatrigelH into immunocompromised mice. Cell fractions that possess S/P activity induce multi-layered tubular outgrowths with secretions surrounded by stroma. We have previously shown that sphere-forming cells as well as basal cells isolated based on coexpression of Trop2 and high levels of CD49f have an increased A functional role for a non-sphere-forming/luminal-enriched fraction appeared to contradict prior published results, in which fractionation of luminal cells based on Trop2/CD49f expression displayed no functional capabilities in vitro and in vivo [6] . To Figure 2 . Isolation of human fetal prostate stroma (hFPS) for use in prostate tissue regeneration assays. A. Gross specimen containing 17-week fetal bladder (FB), prostate (FP), and urethra (U) en block with adjacent panel showing transverse hematoxylin and eosin (H&E) stained histological section. Developing prostate glands budding from the prostatic urethra are surrounded by abundant stroma. B. HFPS cells are cultured in DMEM supplemented with FBS. FACS analysis of cultured hFPS cells using antibodies that target Epcam demonstrates lack of (Epcam+) epithelial cell outgrowth. C. Regenerated graft induced by hFPS after recombination with freshly isolated adult human prostate cells and MatrigelH, followed by subcutaneous injection. H&E staining of paraffin-embedded graft demonstrates tubules with a distinct basal layer, containing cells that express tumor protein 63 (P63+) but lack luminal cell marker expression, including Androgen Receptor (AR), cytokeratin 8 (CK8), and Prostate Specific Antigen (PSA). A luminal layer is identified in the majority of outgrowths and contains cells that are P632, AR+, CK8+, and PSA+. The bottom panel displays the different types of outgrowths identified in recombinant grafts, including epithelial cords (EC), corpora amylacea (CA), and epithelial cords/buds (EC). doi:10.1371/journal.pone.0034219.g002 investigate this discrepancy, FACS analysis comparing Epcam and Trop2 expression was performed to evaluate co-expression of these surface markers. Indeed, there appeared to be almost complete overlap in expression of Trop2 and Epcam, with virtually all Trop2 + cells co-expressing Epcam ( Figure S3A ). On the contrary, high expression CD49f did not appear to be confined to the CD44+ population, since a fraction of CD44 2 cells were CD49f
Hi ( Figure S3B ). CD49f enables functional delineation of putative SCs, PCs, and LCs.
As described above, previous studies indicated that Trop2
+
CD49f
Hi basal cells display both sphere forming and tubule regenerating capabilities, compared to the Trop2 + CD49f
Lo luminal cells, which lack these functional capabilities [4, 6] . 
CD44
2 grafts. After paraffin embedding, sections were made throughout the grafts. The two representative sections containing the highest number of tubules were identified and all tubules present in the low power (4X magnification) field were quantitated. The average numbers of tubules from total grafts obtained from unfractionated or fractionated cells are complied for the graph. Statistical analysis was performed using standard one-way ANOVA analysis; P, 0.001 (***). doi:10.1371/journal.pone.0034219.g003
2 fractions (Figure 4A and S4 
CD49f
Hi cell fractions were combined with hFPS and Matrigel prior to injection, all of the cell types identified in the original prostate surgical specimens were found in regenerated tissue grafts. 
Discussion
Identifying functionally distinct populations of prostate epithelial cells could provide new insights about the cells of origin for human prostate cancer, by determining which cells within the hierarchy are susceptible to malignant transformation. Additionally, the mechanisms employed by normal prostate SCs that enable interaction with the niche and initiation of tubule development could lead to therapeutic approaches that interfere with similar pathways exploited by cancer cells or contributing to the development of benign prostatic hypertrophy (BPH). revious studies investigating human prostate S/P cells isolated from benign tissues have indicated that both general epithelial and basal antigens (Trop2, CD44, alpha 2 beta 1 -integrin Hi , alpha 6 -integrin Hi (CD49f)) are expressed [1, 2, 4] . In these studies, the ability to form self-renewing prostaspheres coincides with the potential to induce fully differentiated prostate tubules in vivo. In the current study, subpopulations of prostate basal cells with robust sphere-forming capability are distinguished from those with optimal tubule initiating capability based on specific antigenic profiles. Prostate epithelial cells with an increased potential to induce tubules inclusive of basal and luminal cell layers (putative SCs) are incapable of forming prostaspheres in vitro. On the other hand, highly proliferative sphere-forming cells (putative PCs) appear to have more limited potential for tubule initiation. This study is the first to functionally separate prostate epithelial cells based upon sphere-forming versus tubule initiating capabilities. Combinations of antigens that subdivide the basal population and functionally distinguish prostate SCs from PCs have not been reported, with the exception of CD133, a rare surface marker found on less than 1% of basal cells [2] . A recent report regarding a 2 b 1 Hi CD133 + cells indicated that these cells were incapable of forming spheres, but readily formed proliferative monolayer cultures [23] . Additional studies have demonstrated acinar-like outgrowths induced by a 2 b 1 Hi CD133 + cells, in vivo [2] . This combined data suggests that CD133 + cells are non-sphereforming, but possess SC traits of self-renewal and differentiation capability, similar to the Epcam + CD44 2 CD49f Hi population reported here. In previous studies, we have also reported that CD133 expression did not enrich for sphere-forming cells [4] . However, given the surprising new finding of increased tubule formation induced by the non sphere-forming, Epcam
Hi cell fraction, analyzing concomitant expression of CD133 (and other putative SC markers) within this subset, including further fractionation and functional analysis, should be considered.
In previous studies of prostate S/P cells, Trop2, which has an almost identical pattern of expression as Epcam (Trop1) within prostate epithelial cells, was utilized to separate prostate epithelial from stromal and blood cells [1] . One advantage of using Epcam, as an alternative to Trop2, is stable and/or highly expressed Epcam is detected in most adenocarcinomas, as well as metastases, malignant effusions, and cancer stem cells [24] . Confirming the presence of Epcam within the human prostate S/P population may lead to investigations of therapeutic agents targeting Epcam and evaluation of specific effects on prostate SC and PC activity [24, 25] .
In the current study, CD44 expression appears to determine whether Epcam + prostate epithelial cells will form robust spheres (CD44 + ) or remain quiescent in vitro, but induce robust tubule formation in vivo (CD44 2 ). In the neural system, it is a wellrecognized limitation that quiescent neural SCs cannot be isolated using the neurosphere assay [26] . Additionally, it is emphasized that sphere-formation and self-renewal is a trait possessed by both SCs and PCs. In the current study, the antigenic profile of cells with the highest prostate sphere-forming capability is Epcam
Hi . However, sphere-forming cells marked by Epcam +
CD44
+ expression can form tubules in vivo, but at a statistically significant lower rate than non-sphere-forming Epcam +
2 cells. Since previous in vivo studies clearly demonstrate that CD49f
Hi is required for prostate tubule formation, we hypothesized that the Epcam + CD44 2 CD49f
Hi antigenic profile designates non-sphere-forming cells capable of tubule regeneration in vivo. Indeed, this antigenic profile was confirmed in our study to represent a subpopulation of prostate basal cells with relatively robust tubule-initiating capability (compared to Epcam
Hi luminal cells) [6] . In contrast to our sphere results, sub-fractionation of Epcam +
2 cells with increased tubule initiation capability did not appear to further enrich for this activity. One factor that may have contributed to this observation is the fact that FACS sorting with three markers requires longer sort time, which could impact the long-term viability of these cells that is required for in vivo grafting. Despite enrichment with the more refined cell fraction, our results clearly demonstrate an advantage in tubule formation capability compared to luminal Epcam Bona fide SCs should be capable of residing in the quiescent state and become activated to differentiate and form new tubules as needed. With asymmetric cell division, progenitor daughter cells develop with less potential to induce new tubules. In the current study, although some sphere-forming cells retain the potential to induce new tubules, the proportion is far less than the in vitro quiescent Epcam + CD44 2 population. This result implies that prostaspheres contain both SCs and rapidly proliferating progenitors (possible transit-amplifying cells), resulting in an overall decreased potential to induce tubules compared to non-sphereforming SCs. Hence, Epcam + CD44 Hi CD49f Hi cells may be further along the developmental pathway and suggests a hierarchy of prostate epithelial cells.
Although the sphere-forming assays indicate that our putative SCs are quiescent, further studies are needed to evaluate this trait. It has been suggested that sphere-formation is an indicator of selfrenewal, yet we have found that the non-sphere-forming (Epcam +
2 CD49f Hi ) cells are capable of inducing differentiated tubules and regenerated grafts that include the full spectrum of prostate cells found in original surgical specimens, including putative SCs. This data indicates that in addition to differentiation and niche interaction capabilities, the putative SCs are selfrenewing (despite the inability to form spheres).
Taken together, our results suggest that Epcam
Hi cells are non-sphere-forming SCs that may be activated to form tubules when exposed to inductive stroma cells in vivo. Lack of CD44 expression distinguishes non-sphere-forming SCs from the more proliferative state of the CD44 + population, which may contain an increased proportion of PCs with limited induction potential, relative to tubule-initiating SCs. Support for CD44 as a proliferative marker exists. 
Methods
Tissue Digestion and Cell Dissociation.
Human prostate tissue was obtained via a research protocol that was approved by the Office for the Protection of Research Subjects at UCLA and the Greater Los Angeles VA Medical Center. Informed written consent was obtained on all participants where identifying information was included. In cases where no identifying information was included and tissue was acquired in an anonymous fashion at UCLA, an approved Institutional Review Board protocol with written consent was not required by Office for the Protection of Research Subjects. Adjacent tissue specimens were snap frozen in liquid nitrogen or fixed in formalin and paraffin-embedded for histological analysis. Frozen sections were immediately examined by a genitourinary pathologist and cancer foci encircled. Fresh tissue specimens were matched with the frozen section slides to enable macrodissection of benign tissue away from tumor nodules. Typically, 2-10 grams of fresh tissue was allocated for research studies. Tissue specimens were then mechanically and enzymatically digested as previously described [16] . Dissociated tissue containing single cells and organoids was sequentially filtered through 100-mm and 40-mm cell strainer, and then passed repeatedly through a 23-gauge needle, in order to generate a single cell suspension. Cells were counted with a hemocytometer and resuspended in RPMI supplemented with 10% FBS prior to cell sorting or plating in prostasphere cultures. Approximately 1-2 million viable cells per gram of fresh tissue were routinely obtained. 
Magnetic activated cell sorting(MACS).
CD44
+ and Epcam + CD44 2 cells were stained with anti-human CD44-PE-Cy-7 (eBioscience) and analyzed by FACS to evaluate the purity of sorted cells.
Fluorescence-activated cell sorting (FACS).
Prostate cells were suspended in PBS, 2 mM EDTA,0.5%BSA and stained with antibody for 15 minutes at 4uC. Fluorescenceactivated cell sorting and analysis were performed on a BD Special Order FACS Aria II system and Diva v6.1.1 (BD Biosciences). Live single cells were gated based on scatter properties and analyzed for their surface marker expression. Cells were sorted and collected at 4uC using 100um nozzle and 23psi. Antibodies used for FACS include Epcam-PE (Miltenyi Biotech), CD44-FITC (ebioscience), and CD49f-APC (BioLegend).
In vitro prostasphere assay.
Prostate cells were counted and re-suspended in 50:50 Matrigel: PrEGM with a concentration of 5610 3 cells/80microliters. This Matrigel/cellular suspension was plated at the edge of the well on 12-well plates and allowed to solidify by incubation at 37uC for 30 minutes. One milliliter of defined sphere media was then added to each well and plates were replaced in 37uC incubator, as previously described [4] . Quantitation of prostaspheres was performed approximately 10-14 days after plating.
Tissue acquisition, isolation and culture of fetal prostate cells.
Human fetal prostate tissue was acquired from 16-17 week specimens in accordance with federal and state guidelines. Adjacent prostate tissue was snap frozen in liquid Nitrogen or fixed in formalin and paraffin-embedded to evaluate anatomy and glandular architecture. The remainder of the tissue was mechanically and enzymatically digested as described (13) . Dissociated prostate cell suspensions were sequentially filtered through 100-micron and 40-micron filters, and then passed through a 23-gauge needle. Cells were counted with a hemocytometer and resuspended in RPMI supplemented with 10% fetal bovine serum (FBS), penicillin/streptomycin (Mediatech Inc.), and Methyltrienolone R1881 (Sigma) for culture in vitro. After 3 passages, cells were analyzed via FACS to confirm purity of stromal cells (See below). HFBS is cryopreserved and thawed as needed for use in recombination assays.
In vivo tissue regeneration. Immunohistochemistry of tissue sections.
Prostate tissue was paraffin embedded as previously described [33] . Four-micron thick sections of frozen or paraffin embedded tissue were deparaffinized with xylene and rehydrated through a descending series of ethanol washes as described [4] . Antigen retrieval and standard immunoperoxidase procedures were used in combination with primary antibodies, including CK5, CK8 (Convane), p63, androgen receptor (AR), Prostate Specific Antigen (PSA) (Santa Cruz), and CD44 (Abcam).
Real time RT-PCR Analysis.
RNA was extracted using Qiagen RNAeasy Micro Kit, following the manufacturer's instructions. The concentration and purity of total RNA was assessed spectrophotometrically at 260 and 280 nm. CDNA was generated from total RNA (up to 5 mg) using SuperScript III First-Strand Synthesis Kit (Invitrogen). For quantitative Real-time PCR, a Bio-Rad CFX Multicolor Realtime PCR detection system was employed, using the SYBRHGreen Supermix (Bio-Rad Laboratories). Real-time PCR primer pairs for CK8, PSA, AR and p63 were purchased from SABiosciences Corporation. The PCR reaction conditions included an initial step at 95uC for 3 min, followed by 40 cycles at 95uC for 15 s (Melt) and 60uC for 45 s (Anneal/Extend). Detection of PCR products was accomplished by measuring the emitting fluorescence at the end of each reaction step (reaction cycles). Threshold cycle corresponds with the cycle number required to detect a fluorescence signal above the threshold. Calculations were performed by Bio-Rad IQ5 software provided by the manufacturer. Gene expression analysis was performed using the comparative method. 
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